Suppr超能文献

肥胖症药物的获批用途和未获批准的使用情况,以及潜在的新药物治疗选择。

Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.

作者信息

Isidro Mª Luisa, Cordido Fernando

机构信息

Endocrine Department, Complejo Hospitalario Universitario A Coruña As Xubias 84, 15006 A Coruña, Spain.

出版信息

Pharmaceuticals (Basel). 2010 Jan 12;3(1):125-145. doi: 10.3390/ph3010125.

Abstract

Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.

摘要

现有的抗肥胖药物治疗选择仍然非常有限,开发更有效的药物已成为当务之急。实现体重减轻的潜在策略是通过刺激厌食信号或阻断食欲信号来减少能量摄入,以及增加能量消耗。本综述将重点关注已获批的肥胖症药物以及潜在的新药物治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d5/3991023/8af63fa93638/pharmaceuticals-03-00125-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验